GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » Price-to-Funds-From-Operations

ANL (Adlai Nortye) Price-to-Funds-From-Operations : (As of Apr. 08, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Adlai Nortye Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Adlai Nortye Business Description

Industry
Traded in Other Exchanges
N/A
Address
685 US Highway 1, New Jersey Biotechnology Development Center, 2nd floor, North Brunswick, NJ, USA, 08902
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.